Insmed

Insmed

World Rank (Aug-2026)
945
Market Cap (Aug-2026)
27.023 Billion USD
World Rank (Jan-05-2024)
3,388
Market Cap (Jan-05-2024)
4.167 Billion USD
World Rank (Jul-30-2023)
4,448
Market Cap (Jul-30-2023)
2.913 Billion USD
World Rank (Jan-07-2022)
4,793
Market Cap (Jan-07-2022)
3.048 Billion USD
World Rank (Jan-01-2021)
3,958
Market Cap (Jan-01-2021)
3.391 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
INSM
Employee Count
613
Employee Count as of Date
As on 2021
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
606 Million USD
Annual Operating Income in USD
-1,247 Million USD
Annual Net Income in USD
-1,277 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
2,265 Million USD
Total Liabilities in USD
1,526 Million USD
Total Equity in USD
739 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
HealthCare Products
Biotechnology
Biopharmaceutical
Company Website
INSMED INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Insmed is a Biopharmaceutical company. The headquarters is in USA.

Annual Results Summary

INSMED - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022245-478 (Loss)-481 (Loss)
Dec-2021188-367 (Loss)-434 (Loss)
Dec-2020164-265 (Loss)-294 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,656 Million USD.

Total Liabilities as on Dec-2022 was 1,568 Million USD.

Total Equity as on Dec-2022 was 87 Million USD.

Founded Year
1988
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share